Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aztreonam for Inhalation in CF with P. aeruginosa
NCT01055847Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2003
- Primary completion
- Aug 2004
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aztreonam in cystic fibrosis (CF), sponsored by Gilead Sciences. Started Jun 2003; status: completed.
02
Drugs
aztreonam
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01055847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01055847.